Evidence map›Paper›PMID 20079429›Full record

ArticleFree radical biology & medicine2010

CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression.

Igor N Zelko, Michael R Mueller, Rodney J Folz

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Copper in the tumor microenvironment and tumor metastasis.Journal of clinical biochemistry and nutrition · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Extracellular superoxide dismutase and its role in cancer.Free radical biology & medicine · 2017
    Review
  10. Article
  11. Paradoxical roles of dual oxidases in cancer biology.Free radical biology & medicine · 2017
    Review
  12. Tumor necrosis factor-α decreases EC-SOD expression through DNA methylation.Journal of clinical biochemistry and nutrition · 2017
    Article
  13. Article
  14. Article
  15. ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Igor N ZelkoDepartment of Medicine, University of Louisville, KY 40202, USA. igor.zelko@louisville.edu
Michael R Mueller
Rodney J Folz
University of Louisville · US

Funding

REGULATION AND FUNCTION OF EC-SODR01HL064894 · NHLBI · UNIVERSITY OF LOUISVILLE · PI FOLZ, RODNEY J · 2000 to 2009
$2.7M
Mechanisms of lung injury following autologous BMTR01HL074289 · NHLBI · UNIVERSITY OF LOUISVILLE · PI FOLZ, RODNEY J · 2003 to 2006
$1.5M
NHLBI NIH HHS HL074289NHLBI NIH HHS HL64894NHLBI NIH HHS R01 HL064894NHLBI NIH HHS R01 HL074289
6 · The paper itself

Abstract

Extracellular superoxide dismutase (EC-SOD) plays an important role in maintaining normal redox homeostasis in the lung. It is expressed at very high levels in pulmonary fibroblasts, alveolar type II epithelial cells, and smooth muscle cells. The molecular mechanisms governing this cell-specific expression of EC-SOD are mostly unknown. In our previous studies we showed that EC-SOD cell-specific expression was not attributable to differential transcriptional regulation, suggesting that other, possibly epigenetic, mechanisms are involved in regulation of its expression. In this paper, we show high levels of promoter methylation in A549 cells and correspondingly low levels of methylation in MRC5 cells. Inhibition of DNA methyltransferase activity by 5-azacytidine in A549 cells reactivated EC-SOD transcription (2.75+/-0.16-fold, P<0.001), demonstrating the importance of methylation in the repression of EC-SOD expression. Furthermore, methylation of cytosines in the promoter markedly decreased Sp1/Sp3-driven promoter activity to 30.09+/-2.85% (P<0.001) compared to unmethylated promoter. This attenuation of transcription of the promoter/reporter construct was, at least in part, attributable to the binding of the methyl-binding protein MeCP2 in the insect cells. However, no binding of MeCP2 or MBD2 protein to the EC-SOD promoter was detected in mammalian cells in vivo. We also found marked differences in the chromatin organization of the EC-SOD promoter between these two cell lines, further supporting the important role epigenetic modifications play in the regulation of EC-SOD expression.

Indexed as

AnimalsCell Line, TumorChromatin Assembly and DisassemblyCpG IslandsDNA MethylationDrosophilaEpigenesis, GeneticEpithelial CellsExtracellular SpaceHumansLungMethyl-CpG-Binding Protein 2MethyltransferasesOrgan SpecificityOxidation-ReductionPromoter Regions, GeneticMethyl-CpG-Binding Protein 2MethyltransferasesSp1 Transcription FactorSp3 Transcription FactorSuperoxide Dismutase

Identifiers

PMID20079429
PMCPMC2838251
OpenAlexW2023703768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.